A 16-year-old girl is found to have a 8 cm right ovarian mass on imaging performed for evaluation of abdominal pain. Tumor markers show AFP 12 IU/mL (normal <10), β-hCG 8 mIU/mL (normal <5), and LDH 180 U/L (normal <250). Imaging shows no ascites, no peritoneal deposits, and normal lymph nodes. Staging laparotomy confirms a stage IA immature teratoma (grade 2). What is the most appropriate next step in management?

Explanation

## Clinical Context This is a young adolescent with a stage IA immature teratoma (grade 2). The key clinical decision is whether adjuvant chemotherapy is indicated based on stage and grade. ## Immature Teratoma: Grade and Stage Prognostic Factors | Grade | Histology | Prognosis | |-------|-----------|----------| | **Grade 1** | Minimal immature tissue | Excellent; observation may suffice for stage IA | | **Grade 2** | Moderate immature tissue | Intermediate; adjuvant chemotherapy indicated for stage IA | | **Grade 3** | Abundant immature tissue | Poor; chemotherapy essential | **Key Point:** The grade of immature teratoma is the MOST important prognostic factor. Grade 2 and 3 immature teratomas carry significant risk of recurrence even in stage IA disease and require adjuvant chemotherapy. ## Management Algorithm for Stage IA Immature Teratoma ```mermaid flowchart TD A[Stage IA Immature Teratoma]:::outcome A --> B{Grade?}:::decision B -->|Grade 1| C[Observation with tumor marker monitoring]:::action B -->|Grade 2 or 3| D[Adjuvant chemotherapy: BEP × 3–4 cycles]:::action D --> E[Tumor marker monitoring during chemotherapy]:::action E --> F[Post-chemotherapy imaging and markers]:::action F --> G[Long-term follow-up: 5 years]:::action ``` ## Why Adjuvant Chemotherapy is Correct for Grade 2 **High-Yield:** - **Grade 1 stage IA immature teratoma:** Observation may be acceptable (>95% cure rate) - **Grade 2 stage IA immature teratoma:** Adjuvant chemotherapy is standard (BEP × 3–4 cycles) because recurrence risk is 15–20% without treatment - **Grade 3 or any stage ≥IB:** Chemotherapy is mandatory **Clinical Pearl:** Immature teratomas are highly chemosensitive. Even with adjuvant chemotherapy, cure rates exceed 95% for stage IA disease. This justifies the use of chemotherapy to reduce recurrence risk in a young woman with her entire reproductive life ahead. **Mnemonic:** **GRADE-2-GETS-CHEMO** — Grade 2 immature teratoma (stage IA) requires adjuvant chemotherapy to reduce recurrence risk from ~20% to <5%. ## Why Observation Alone is Insufficient Although this is stage IA (excellent prognosis), grade 2 histology carries a 15–20% recurrence risk without adjuvant treatment. Observation alone would be appropriate only for grade 1 tumors.